| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDXS | Common Stock | Sale | -$246,391 | -7,800 | -13.33% | $31.59* | 50,712 | 13 Dec 2021 | Direct | F1, F2 |
| transaction | CDXS | Common Stock | Sale | -$6,428 | -200 | -0.39% | $32.14* | 50,512 | 13 Dec 2021 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2021. |
| F2 | The shares were sold in multiple transactions at per share prices ranging from $31.09 to $31.95. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |